Santhera Pharmaceuticals Holding AG (S3F0) Stock Price & News

All values in CHF	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	12.01M	12.01M	26.59M	26.59M
Cost of goods sold	16.06M	16.06M	14.94M	14.94M
Cost of revenue	16.06M	16.06M	14.94M	14.94M
Research and development expenses	5.85M	5.85M	5.26M	5.26M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	7.82M	7.82M	7.57M	7.57M
Operating expense	13.67M	13.67M	12.73M	12.73M
Total operating expenses	29.73M	29.73M	27.67M	27.67M
Operating income	-17.72M	-17.72M	-1.08M	-1.08M
Other non operating income	2.03M	2.03M	-577.00K	-577.00K
EBT including unusual items	-19.38M	-19.38M	-5.15M	-5.15M
EBT excluding unusual items	-19.38M	-19.38M	-5.20M	-5.20M
Income tax expense	37.50K	37.50K	55.00K	55.00K
Effective tax rate	-0.19%	-0.19%	-1.07%	-1.07%
Other operating expenses	-	-	-102.00K	-102.00K
Net income	-19.42M	-19.42M	-5.20M	-5.20M
Net profit margin	-161.71%	-161.71%	-19.57%	-19.57%
Earnings per share	-	-	-	-
Interest and investment income	177.50K	177.50K	27.00K	27.00K
Interest expense	-2.40M	-2.40M	-3.38M	-3.38M
Net interest expenses	-2.22M	-2.22M	-3.35M	-3.35M
Depreciation and amortization charges	-	-	-	-
EBITDA	-16.30M	-16.30M	35.00K	35.00K
Gain or loss from assets sale	-	-	-	-

Finance